Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology ®
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their latest skincare innovation with the introduction of Restorative Skin Complex with Next Generation TriHex Technology® (TriHex+™). This newly enhanced formula can be used as a multi-functional, daily rejuvenating serum to support the skin’s natural collagen and elastin production that declines from aging as well as the visible loss of volume in skin impacted by factors such as facial aging or medication-driven weight loss. Restorative Skin Complex with TriHex+ joins ALASTIN’s other world class and award-winning products that are science-led and physician-endorsed.
The much-loved Restorative Skin Complex formula has been enhanced with two groundbreaking additions. The first is an innovation to the patented TriHex Technology with the addition of Octapeptide-45, a proprietary, patent-pending peptide that amplifies the skin’s natural ability to regenerate collagen and elastin addressing the appearance of fine lines, radiance, skin plumping and long-lasting hydration. In addition, the new formula includes a novel ingredient, Magnolol, which helps stimulate depleted fat tissue (adipocytes). These new ingredients help to visibly restore desired facial radiance and plumping by supporting the skin’s own regenerative abilities that decline as we age, especially from age of 25 and up, when we begin losing around 1% of our collagen a year.1
“Galderma’s team is constantly evaluating unmet skin care needs and how we can elevate our products to address them. Concerns like loss of collagen and elasticity, along with the loss of volume as a result of medication-driven weight loss or other factors, have been at the forefront of patient concerns with their skin specialists. We knew we had to do more to help restore their ‘good fat’ while also regenerating the collagen and elastin that can degrade over time.” ALAN D. WIDGEROW, MBBCH, MMED, FCS, FACS CHIEF SCIENTIFIC OFFICER GALDERMA, HEAD SKIN SCIENCE
|
ALASTIN will be launching the newly enhanced Restorative Skin Complex with TriHex+ this month in the United States. It will be available exclusively from authorized ALASTIN skincare providers at dermatology offices, clinics and medispas. Galderma is working to bring this new innovation to other international markets where ALASTIN is already available.
“Adding ingredients to further support the appearance of elasticity and skin volumization to a much-loved product that already delivers anti-aging, hydration, and visible volume facial plumping benefits represents a significant clinical and scientific breakthrough.” DEANNE MRAZ, MD, FAAD PRESIDENT AND FOUNDER, DMR RESEARCH PRESIDENT AND CO-FOUNDER, MODERN DERMATOLOGY ASSISTANT CLINICAL PROFESSOR OF DERMATOLOGY, YALE NEW HAVEN HOSPITAL |
About Galderma
Galderma (SWX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
15 Signs Your Skin Is Losing Collagen | Vogue
View source version on businesswire.com: https://www.businesswire.com/news/home/20250416998801/en/
Contacts
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62
Jeffrey Smith
Head of U.S. Communications
Jeffrey.smith@galderma.com
+1 (682) 401-8428
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Announces New Assignments of Directors25.6.2025 10:07:00 EEST | Press release
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members serving as external directors out of a total of 14 members, helping to ensure transparency and objectivity. An external director will continue to chair the Board of Directors. The Audit and Supervisory Committee, the Nomination Committee and the Compensation Committee will be composed solely of external directors including their chairs. Takeda highly values strong, independent governance and its Board of Directors helps to ensure that all decisions and actions are in the best interests of global stakeholders and aligned with the company’s values. This robust corporate governance model has been, and will continue to be, critical to Takeda's success. Details of the new assignments are as follows: 1. New Assignment of Directors Who Are Not Audit and Supervis
Anew Climate and Aurora Sustainable Lands Collaborate with Microsoft to Deliver Landmark 10-Year Agreement for Carbon Removal Credits25.6.2025 10:00:00 EEST | Press release
Anew Climate and Aurora Sustainable Lands today announced a 10-year agreement with Microsoft to deliver 4.8 million nature-based carbon removal credits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625732509/en/ The deal supports one of the largest permanent working forest carbon removal efforts in the United States, and will provide investments and jobs across timberland communities. The projects, developed by Anew Climate and owned and managed by Aurora Sustainable Lands, span ecologically diverse forestlands in New York, Virginia, West Virginia, Kentucky, and Florida and utilize Improved Forest Management (IFM) to generate nature-based removal credits. Removals from these projects will be among the first issued under ACR’s IFM v2.1 protocol, a next-generation methodology that advances the field via dynamic baselines, enhanced additionality and monitoring requirements, improved quantification accuracy, and increased t
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin25.6.2025 08:00:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients living with Systemic Sclerosis (SSc) and Chronic Pruritus of Unknown Origin (CPUO) – two chronic conditions with high unmet need.1-3,7 Nemolizumab is a monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31, a neuroimmune cytokine that plays a role in driving itch – the main symptom of CPUO – and inflammation and fibrosis, which are hallmarks of SSc.1,3,4 “Investigating nemolizumab in two new trials in Systemic Sclerosis and Chronic Pruritus of Unknown Origin, both of which are associated with poor patient outcomes and low quality of life, underscores our commitment to addressing skin conditions with high unmet needs. These trials may help us better understand these complex diseases and offer hope for patients seeking relief from these sever
MSCI Announces Results of the MSCI 2025 Market Classification Review25.6.2025 00:55:00 EEST | Press release
MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today the results of the MSCI 2025 Market Classification Review. Select highlights of this year’s review includes MSCI: Extending the consultation on a potential reclassification of Bulgaria from Standalone to Frontier Market status Continuing to monitor the implementation and market adoption of measures to enhance the accessibility of the Korean equity market, to determine whether these measures have replicated the outcomes of fully operational offshore FX markets such as those found in Developed Markets Providing updates on the market classification status of Greece Continuing to monitor the market accessibility of the Bangladesh equity market “MSCI is committed to ensuring that our market classifications reflect the evolving realities of global accessibility and investability,” said Raman Aylur Subramanian, Head of Index R&D. “In 2025, we have see
Jørgen Vig Knudstorp Nominated to Join NIKE, Inc. Board of Directors24.6.2025 23:15:00 EEST | Press release
NIKE, Inc. (NYSE:NKE) today announced Jørgen Vig Knudstorp has been nominated for election to its Board of Directors at the Company’s 2025 annual meeting of shareholders, to be held on September 9, 2025. Mr. Knudstorp was President and Chief Executive Officer of the LEGO Group (“LEGO”) from 2004 to 2016, Executive Chair of LEGO Brand Group from 2017 to 2023 and currently serves as Deputy Chair of the LEGO Foundation. He previously held various leadership positions at LEGO from 2001 to 2004. “Jørgen’s strong global experience with brand and digital marketing, strategy, and consumer products, as well as his development and fostering of culture and values, will make him an excellent addition to our board,” said Mark Parker, Executive Chairman of NIKE, Inc. “We look forward to working with Jørgen during an exciting time for NIKE where we will unlock our next chapter of growth through innovative product and distinctive brand storytelling across an integrated marketplace.” Prior to joining L
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom